1. Home
  2. GAUZ vs VTYX Comparison

GAUZ vs VTYX Comparison

Compare GAUZ & VTYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAUZ
  • VTYX
  • Stock Information
  • Founded
  • GAUZ 2009
  • VTYX 2018
  • Country
  • GAUZ Israel
  • VTYX United States
  • Employees
  • GAUZ N/A
  • VTYX N/A
  • Industry
  • GAUZ Industrial Machinery/Components
  • VTYX Medicinal Chemicals and Botanical Products
  • Sector
  • GAUZ Miscellaneous
  • VTYX Health Care
  • Exchange
  • GAUZ Nasdaq
  • VTYX Nasdaq
  • Market Cap
  • GAUZ 193.8M
  • VTYX 154.9M
  • IPO Year
  • GAUZ 2024
  • VTYX 2021
  • Fundamental
  • Price
  • GAUZ $10.68
  • VTYX $1.94
  • Analyst Decision
  • GAUZ Strong Buy
  • VTYX Buy
  • Analyst Count
  • GAUZ 4
  • VTYX 4
  • Target Price
  • GAUZ $16.25
  • VTYX $11.33
  • AVG Volume (30 Days)
  • GAUZ 73.3K
  • VTYX 1.9M
  • Earning Date
  • GAUZ 02-10-2025
  • VTYX 02-25-2025
  • Dividend Yield
  • GAUZ N/A
  • VTYX N/A
  • EPS Growth
  • GAUZ N/A
  • VTYX N/A
  • EPS
  • GAUZ N/A
  • VTYX N/A
  • Revenue
  • GAUZ $94,346,000.00
  • VTYX N/A
  • Revenue This Year
  • GAUZ $34.69
  • VTYX N/A
  • Revenue Next Year
  • GAUZ $35.73
  • VTYX N/A
  • P/E Ratio
  • GAUZ N/A
  • VTYX N/A
  • Revenue Growth
  • GAUZ 29.76
  • VTYX N/A
  • 52 Week Low
  • GAUZ $6.78
  • VTYX $1.67
  • 52 Week High
  • GAUZ $17.10
  • VTYX $11.48
  • Technical
  • Relative Strength Index (RSI)
  • GAUZ N/A
  • VTYX 39.33
  • Support Level
  • GAUZ N/A
  • VTYX $2.10
  • Resistance Level
  • GAUZ N/A
  • VTYX $2.61
  • Average True Range (ATR)
  • GAUZ 0.00
  • VTYX 0.18
  • MACD
  • GAUZ 0.00
  • VTYX -0.05
  • Stochastic Oscillator
  • GAUZ 0.00
  • VTYX 5.67

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a integrated light and vision control company, Its products include suspended particle device, or SPD, and liquid crystal, or LC, films for smart glass applications, as well as camera monitoring systems, or CMS, and other advanced driver assistance systems, or ADAS, solutions. It has three operating segments. Architecture and automotive segment focuses on sales that enable OEMs to incorporate the Company's technology in glass rooftops, side windows and windshields. Safety tech segment focuses on sales of advanced driver assistance systems for buses, coaches, recreational vehicles and specific vehicles. Aeronautics segment focuses on the sale of shading and cabin management systems in private and commercial aircraft and helicopters. Key revenue is generated from Aeronauctis.

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

Share on Social Networks: